We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+9.91%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+258.3%
AUM
$1.1B
AUM Growth
+$73.5M
Cap. Flow
-$16.3M
Cap. Flow %
-1.48%
Top 10 Hldgs %
28.91%
Holding
248
New
4
Increased
56
Reduced
116
Closed
11

Top Buys

Rank Stock Value
1
ZBRA icon
Zebra Technologies
ZBRA
+$2.39M
2
ABBV icon
AbbVie
ABBV
+$1.05M
3
SYK icon
Stryker
SYK
+$910K
4
APD icon
Air Products & Chemicals
APD
+$856K
5
RLAY icon
Relay Therapeutics
RLAY
+$805K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.51M
2
MIDD icon
Middleby
MIDD
+$2.65M
3
MRSH
Marsh
MRSH
+$1.4M
4
AMZN icon
Amazon
AMZN
+$1.02M
5
AFL icon
Aflac
AFL
+$1M

Sector Composition

Rank Sector Weight
1 Technology 22.19%
2 Healthcare 16.25%
3 Financials 9.14%
4 Industrials 8.55%
5 Consumer Discretionary 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NEE icon
26
NextEra Energy
NEE
$177B
$13.2M 1.2%
190,884
+2,448
+1% +$169K
SYK icon
27
Stryker
SYK
$130B
$12.9M 1.17%
61,972
+4,680
+8% +$910K
VWO icon
28
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$12.6M 1.14%
291,243
+155
+0.1% +$6.74K
CRM icon
29
Salesforce
CRM
$158B
$12.2M 1.1%
48,401
+3,004
+7% +$658K
MDY icon
30
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
$12.1M 1.1%
35,655
-1,379
-4% -$471K
ABT icon
31
Abbott
ABT
$187B
$11.3M 1.03%
103,878
-110
-0.1% -$11.2K
ADBE icon
32
Adobe
ADBE
$105B
$10.7M 0.97%
21,758
+815
+4% +$379K
DHR icon
33
Danaher
DHR
$144B
$10.5M 0.95%
55,096
-1,183
-2% -$210K
TEL icon
34
TE Connectivity
TEL
$62.6B
$10.4M 0.95%
106,572
-314
-0.3% -$28.9K
PEP icon
35
PepsiCo
PEP
$190B
$10.3M 0.94%
74,647
+521
+0.7% +$70.9K
IJR icon
36
iShares Core S&P Small-Cap ETF
IJR
$112B
$10.3M 0.93%
146,134
-9,154
-6% -$656K
GIS icon
37
General Mills
GIS
$19.7B
$10.2M 0.92%
164,568
-10,567
-6% -$660K
IDXX icon
38
Idexx Laboratories
IDXX
$46.2B
$10.1M 0.92%
25,722
-86
-0.3% -$31.8K
QQQ icon
39
Invesco QQQ Trust
QQQ
$481B
$10.1M 0.92%
36,314
-2,523
-6% -$684K
SPGI icon
40
S&P Global
SPGI
$120B
$10M 0.91%
27,865
-59
-0.2% -$20.8K
VZ icon
41
Verizon
VZ
$196B
$9.11M 0.83%
153,119
+1,186
+0.8% +$68.9K
CVS icon
42
CVS Health
CVS
$122B
$9.07M 0.82%
155,274
+214
+0.1% +$13.3K
DLTR icon
43
Dollar Tree
DLTR
$25.2B
$8.41M 0.76%
92,050
-1,520
-2% -$143K
MCD icon
44
McDonald's
MCD
$195B
$7.99M 0.73%
36,403
-34
-0.1% -$6.98K
MRK icon
45
Merck
MRK
$318B
$7.43M 0.67%
93,920
+753
+0.8% +$59K
ABBV icon
46
AbbVie
ABBV
$435B
$7.38M 0.67%
84,301
+11,163
+15% +$1.05M
XBI icon
47
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$6.99M 0.63%
62,702
-389
-0.6% -$43.6K
JPM icon
48
JPMorgan Chase
JPM
$950B
$6.34M 0.58%
65,852
+142
+0.2% +$13.9K
HD icon
49
Home Depot
HD
$355B
$6.33M 0.57%
22,781
-549
-2% -$149K
SHW icon
50
Sherwin-Williams
SHW
$89.8B
$6.15M 0.56%
26,481
+219
+0.8% +$47.8K
1
2
3 4 5

Similar funds

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
SGM
Seven Grand Managers Bronxville, New York $1.5B AUM 57.16% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CPA
Capital Performance Advisors Walnut Creek, California $1.5B AUM 21.4% 1-Year Est. Return
MCM
Maple Capital Management Montpelier, Vermont $1.49B AUM 23.46% 1-Year Est. Return

Boston Family Office's Q3 2020 Portfolio in Review

As of Q3 2020, Boston Family Office held 248 positions worth $1.1B, up 7.1% from $1.03B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Boston Family Office's Q3 2020 filing shows 4 new, 56 increased, 116 reduced and 11 closed positions. Its largest new stake was Relay Therapeutics: 21,121 shares worth $900K. The largest sale was Apple, an estimated $4.51M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Boston Family Office's largest Q3 2020 buy was Relay Therapeutics: 21,121 shares worth $900K.
  • Boston Family Office added most to Zebra Technologies in Q3 2020, an estimated $2.39M increase.
  • Boston Family Office's biggest Q3 2020 reduction was Apple, cutting an estimated $4.51M.
  • Boston Family Office fully exited ICU Medical in Q3 2020, selling an estimated $829K.
  • Boston Family Office's ten largest holdings make up 29% of its $1.1B portfolio in Q3 2020.
  • Boston Family Office opened 4 new positions and closed 11 in Q3 2020.
  • Boston Family Office's portfolio value rose 7.1% quarter-over-quarter to $1.1B.

Based on Boston Family Office's 13F filing for Q3 2020, filed 10 Nov 2020.